Scynexis Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.11
Dividend & YieldN/A$ (N/A)
Beta 1.82
Market capitalization 77.72M
Operating cash flow -82.6M
ESG Scores unknown

Company description

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial Ratios
Quick Ratio8.03
Working Capital-0.34
Return On Equity-0.8
Debt To Equity0.98
Fixed Asset Ratio0.16
Fixed Interest Cover-15.35

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -38k 5.09M -2.6M 2.76M
Total Cashflows From Investing Activities -803k 26.24M 6.47M -1.17M
Net Borrowings 27k 27k 10M 30M
Total Cash From Financing Activities 29.42M 42.3M 94M 67.12M
Change To Operating Activities -6.37M 3.25M -618k 6.54M
Issuance Of Stock 31.7M 46.39M 90.58M 38.57M
Net Income -12.47M -53.71M -55.19M -32.87M
Change In Cash 298k 30.43M 51.12M 11.39M
Effect Of Exchange Rate
Total Cash From Operating Activities -28.32M -38.12M -49.35M -54.56M
Depreciation 53k 111k 111k 379k
Change To Account Receivables -861k -861k -861k -861k
Other Cashflows From Financing Activities -2.27M -4.11M -6.37M -1.45M
Change To Netincome -10.16M 5.96M 7.74M -26.52M
Capital Expenditures -565k -4k -4k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 21.56M 38.39M 36.52M 23.77M
Income Before Tax -19.2M -53.71M -58.33M -35.95M
Net Income -12.47M -53.71M -55.19M -32.87M
Selling General Administrative 8.68M 10.65M 14.63M 49.92M
Gross Profit 257k 121k 12.85M
Ebit -29.98M -48.92M -51.15M -60.84M
Operating Income -29.98M -48.92M -51.15M -60.84M
Interest Expense -2.05M -2.16M -2.38M -3.96M
Income Tax Expense -6.74M -3.15M -3.09M
Total Revenue 257k 121k 13.16M
Cost Of Revenue 312k
Total Other Income ExpenseNet 10.78M -4.79M -7.18M 24.88M
Net Income From Continuing Ops -12.47M -53.71M -55.19M -32.87M
Net Income Applicable To Common Shares -12.47M -53.71M -55.19M -32.87M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 21.95M 44.26M 79.78M 78.58M
Total Stockholder Equity 31.23M 12.89M 22.76M 41.26M
Other Current Liabilities 121k 17.56M
Total Assets 53.17M 57.15M 102.54M 119.84M
Common Stock 48k 10k 20k 32k
Other Current Assets 109k 674k 373k 4k
Retained Earnings -217.72M -271.43M -326.61M -359.48M
Treasury Stock
Cash 11.44M 41.92M 93.04M 104.48M
Total Current Liabilities 5.88M 11.01M 26.4M 13.62M
Other Stockholder Equity
Property, Plant, and Equipment 516k 3.6M 3.3M 2.91M
Total Current Assets 51.46M 52.4M 98.21M 109.38M
Net Tangible Assets 31.23M 12.89M 22.76M 40.2M
Net Receivables 6.73M 2.88M 861k
Accounts Payable 3.65M 7.18M 4.64M 7.85M


Insider Transactions

Here are the insider transactions of stock shares related to Scynexis Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
MACLEOD IVORStock Award(Grant) at price 0.00 per share.D2022-10-24Chief Financial Officer15k
ANIDO ARMANDOStock Award(Grant) at price 0.00 per share.D2022-06-17Director10k
HASTINGS DAVID CStock Award(Grant) at price 0.00 per share.D2022-06-17Director10k
HANHAM ANN FStock Award(Grant) at price 0.00 per share.D2022-06-17Director10k
MACDONALD GUYStock Award(Grant) at price 0.00 per share.D2022-06-17Director10k
GILMAN STEVEN CStock Award(Grant) at price 0.00 per share.D2022-06-17Director10k
TINMOUTH BRIAN PHILIPPEStock Award(Grant) at price 0.00 per share.D2022-06-17Director10k
TAGLIETTI MARCOPurchase at price 2.30 per share.D2022-04-26Chief Executive Officer75k
SUKENICK SCOTT A. J.D.Purchase at price 2.30 per share.D2022-04-26General Counsel3.5k
TAGLIETTI MARCOStock Award(Grant) at price 0.00 per share.D2022-02-04Chief Executive Officer87.2k
ANGULO GONZALEZ DAVIDStock Award(Grant) at price 0.00 per share.D2022-02-04Officer51.1k
SUKENICK SCOTT A. J.D.Stock Award(Grant) at price 0.00 per share.D2022-02-04General Counsel40.7k
COYNE CHRISTINEStock Award(Grant) at price 0.00 per share.D2022-02-04Officer43.2k
COYNE CHRISTINEStock Award(Grant) at price 0.00 per share.D2021-05-10Officer15k
PERCEPTIVE ADVISORS, L.L.C.Sale at price 7.38 - 8.95 per share.I2021-01-22Beneficial Owner of more than 10% of a Class of Security599k
ANIDO ARMANDOPurchase at price 6.25 per share.D2020-12-21Director5k
HANHAM ANN FPurchase at price 6.25 per share.D2020-12-21Director3.2k
MACDONALD GUYPurchase at price 6.25 per share.D2020-12-21Director8k
TAGLIETTI MARCOPurchase at price 6.25 per share.D2020-12-21Chief Executive Officer40k
GILMAN STEVEN CPurchase at price 6.25 per share.D2020-12-21Director4k
ANGULO GONZALEZ DAVIDPurchase at price 6.25 per share.D2020-12-21Officer1.6k
FRANCOIS ERIC SPurchase at price 6.25 per share.D2020-12-21Chief Financial Officer600
SUKENICK SCOTT A. J.D.Purchase at price 6.25 per share.D2020-12-21General Counsel1.6k
TINMOUTH BRIAN PHILIPPEPurchase at price 6.25 per share.D2020-12-21Director8k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Scynexis Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Scynexis Inc

Here is the result of two systematic investment strategies applied to Scynexis Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Scynexis Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Scynexis Inc:

Scynexis Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -35.42% on the backtest period.

Performance at glance

Performance

-35.42 %

Latent gain

-804.83 $

Invested capital

2272.37 $

Annualized return

-8.56 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Scynexis Inc

This is the result of two momentum investment strategies applied to Scynexis Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Scynexis Inc

The following chart shows all the entries opened by the momentum investment system on Scynexis Inc:

Scynexis Inc momentum entries
  • The first momentum investment strategy would give -25.99% of return on Scynexis Inc. That represents -1299.19$ of latent gain with 4998.73$ of employed capital.
  • The second momentum investment strategy would give -27.79% of return on Scynexis Inc. That represents -974.73$ of latent gain with 3508.05$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-25.99 %

Latent gain

-1299.19 $

Invested capital

4998.73 $

Annualized return

-8.81 %
Performance at glance (2Q Momentum)

Performance

-27.79 %

Latent gain

-974.73 $

Invested capital

3508.05 $

Annualized return

-7.59 %

Momentum equity curve on Scynexis Inc

The following chart shows the equity curve of the two momentum strategies applied to Scynexis Inc:

Scynexis Inc momentum equity

Note: the dividends potentially given by Scynexis Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Scynexis Inc

The following chart shows the employed capital evolution of the two momentum strategies on Scynexis Inc since the beginning:

Scynexis Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Scynexis Inc

Buy the dip entry openings on Scynexis Inc

Scynexis Inc

The performance achieved by the robo-advisor on Scynexis Inc is -18.86%. That represents -141.38$ of latent gain with 749.61$ of employed capital. The following chart shows Scynexis Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Scynexis Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-18.86 %

Latent gain

-141.38 $

Invested capital

749.61 $

Annualized return

-8.81 %

Equity curve of the strategy applied to Scynexis Inc

The following chart shows the result of the investment strategy applied to Scynexis Inc:

Scynexis Inc

Note: the dividends potentially given by Scynexis Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Scynexis Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Scynexis Inc:

Scynexis Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Scynexis Inc

In this section, I will compare the three previous investment strategies applied to Scynexis Inc.

Equity curve comparison on Scynexis Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Scynexis Inc investment strategy comparison

Employed capital comparison on Scynexis Inc

Scynexis Inc investment comparison

Performance comparison on Scynexis Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -35.42% -804.83$ 2272.37$ -8.56%
Momentum 1 quarter -25.99% -1299.19$ 4998.73$ -6.66%
Momentum 2 quarters -27.79% -974.73$ 3508.05$ -7.59%
Non-directional -18.86% -141.38$ 749.61$ -8.81%
Annualized return comparison

Automatic investment

-8.56 %

Momentum 1Q

-7.59 %

Momentum 2Q

-7.59 %

Non-directional

-8.81 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Scynexis Inc:

Note: The algorithm computes the probability of correlation between Scynexis Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Scynexis Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Scynexis Inc
Country United States
City Jersey City
Address 1 Evertrust Plaza
Phone 201 884 5485
Website www.scynexis.com
FullTime employees 56
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Exchange XNAS
Ticker SCYX
Market www.nasdaq.com

Scynexis Inc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown